Fernando Carmona García*

Bachelor's Degree in Pharmaceutical Chemist Biologist, Universidad Juárez Autónoma de Tabasco-División Académica de Ciencias Básicas, Cunduacán, Tabasco, México

*Corresponding Author: Fernando Carmona García, Bachelor's Degree in Pharmaceutical Chemist Biologist, Universidad Juárez Autónoma de Tabasco-División Académica de Ciencias Básicas, Cunduacán, Tabasco, México.

Received: March 20, 2024; Published: April 10, 2024

Abstract

Diabetes is a chronic disease that originates once the pancreas can no longer produce insulin or when the body cannot use this hormone efficiently, characterized by being an irreversible metabolic disorder that greatly undermines the health and hope of life of the people. It is classified into 3 types: type 1 diabetes, type 2 diabetes and gestational diabetes.
The present research proposes, within a general overview, an update to the reader about diabetes in Mexico; developing themes with recent literature on the subject and thus provide new perspectives on this important public health problem.

Keywords: Public Health; Diabetes; México; Quality of Life; Deterioration of Health

References

1. International Diabetes Federation. “Facts & figures”. IDF, 26 February (2024).
2. “World Health Statistics 2023”. WHO, 29 May (2023).
3. Medina-Chávez Juan Humberto., et al. “Comprehensive Care Protocol: chronic complications of type 2 diabetes mellitus”. Medical Journal of the Mexican Social Security Institute1 (2022): S19-S33.
4. IDF Diabetes atlas. “Diabetes Report 2000 – 2045 México”. IDF (2021).
5. Mexico´s goverment. Hablemos de salud-Acciones y programas. “Diabetes en México”. Mexico´s goverment, February 27, (2024).
6. “With the IMSS Comprehensive Care Protocol, it serves more than 3.5 million beneficiaries with diabetes”. IMSS, June 16, (2023).
7. Basto-Abreu A., et al. “Prevalence of Prediabetes and Diabetes in Mexico: Ensanut 2022”. Public Health of Mexico 65 (2023): s163-s168.
8. Pan American Health Organization. “World Diabetes Day 2023”. PAHO, November 14, (2023).
9. Russo María P., et al. "Prevalence of diabetes, epidemiological characteristics and vascular complications”. Archives of Cardiology of Mexico1 (2023).
10. Vega-Silva Erika Lorena., et al. “Quality of life and caregiver burden in caregivers with patients with complications from type 2 diabetes mellitus”. Medical Journal of the Mexican Social Security Institute4 (2023): 440-448.
11. Ruano Imbaquingo D E., et al. “Current Treatment of Type 2 Diabetes Mellitus”. Ciencia Latina Multidisciplinary Scientific Magazine2 (2023): 379-395.
12. Godina Ortiz and Blanca Aideé. “Economic Evaluation of oral Semaglutide in monotherapy for the treatment of patients with Type 2 Diabetes Mellitus who do not achieve appropriate glycemic control (HbA1c ≤ 7) from the perspective of the Mexican Social Security Institute”. International University of La Rioja, Master's thesis (2023).
13. Rumié Carmi Hana Karime., et al. "New Insulins in the treatment of Type 1 Diabetes". Andes Pediatrica 3 (2023): 278.
14. Zumba Vera and Dayana Patricia. “Complications of type II diabetes mellitus in older adults at the national level 2023”. Universidad Católica De Cuenca, Bachelor's tesis (2024).
15. Government of Mexico. "Front labeling of food and beverages". gob.mx, October 5 (2021).
16. Mora Romo José Fernando. “Adherence to Treatment in People with Type 2 Diabetes Mellitus in Mexico: Meta-analysis Study”. Psicumex1 (2022): 1-20.

Citation

Citation: Fernando Carmona García., et al. “Recent Overview of Diabetes in Mexico and its Impact on Public Health".Acta Scientific Nutritional Health 8.5 (2024): 20-24.

Copyright

Copyright: © 2024 Fernando Carmona García., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.